BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Aug. 5, 2005
View Archived Issues
FDA Committee Wants More Data For MT 100 In Migraine
ROCKVILLE, Md. - Prospects are growing dim for MT 100, a migraine drug developed by Pozen Inc. (BioWorld Today)
Read More
ZymoGenetics Gets $135M To Advance rhThrombin
Read More
Par Dropping Advancis Deal After Amoxicillin Pulsys Miss
Read More
Predix IPO Seeks $70M; Phase III Program Starts
Read More